← back to explore
Cornelia Bargmann
Researchers / independent engineers · Science/Research · milestone at age 26 ·
T1 Global iconMilestone (age 26)
Completed PhD at MIT in 1987 at age 26, having cloned the neu/HER2 oncogene in Robert Weinberg's lab, a discovery that led to the development of Herceptin for breast cancer.
Born in Virginia and raised in Georgia, Bargmann studied biochemistry at the University of Georgia before joining Robert Weinberg's lab at MIT, where she cloned the HER2 oncogene as a graduate student, a finding that directly led to the targeted cancer therapy Herceptin.
Starting point
Born in Virginia in 1961 and raised in Athens, Georgia; attended the University of Georgia for undergraduate studies in biochemistry.
Current position (2025)
Torsten N. Wiesel Professor at Rockefeller University; Head of the Wang Laboratory of Neural Circuits and Behavior; Howard Hughes Medical Institute investigator; Head of Science at Chan Zuckerberg Initiative.
How this path compounded
01 Starting advantages
7/24 starting-position score
Strongest documented signals: Elite institution pipeline, Dedicated mentor / coach, Frontier geography.
Describes the starting position, not what the person later made of it.
Cohort percentile: 57
02 Built or converted leverage
16/25 multiplying-capacity score
Strongest observed levers:Scarce skill depth, Elite ecosystem network, Concentration intensity.
Measures what was present, not whether it was inherited, earned, self-built, external, or mixed.
Cohort percentile: 92
03 Compounding trajectory
8 documented steps
The timeline below shows the sequence of work and transitions around the selected early milestone. It is evidence of a path, not proof that every step was necessary.
Milestone at age 26
04 Observed career standing
T1 · Global icon
Legendary or globally iconic career standing. The tier summarizes documented career recognition through the data cutoff—not Cornelia Bargmann's worth or future potential.
Question four · where did the leverage come from?
Cornelia Bargmann's leverage provenance
Each non-zero lever gets a best-supported origin, evidence signals, and confidence. Unresolved is the honest default when the biography cannot distinguish self-built, advantage-enabled, earned, external, or mixed.
Scarce skill depth3/3
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Rare early tools (1/2)Dedicated mentor / coach (2/2)Elite institution pipeline (2/2)
Elite ecosystem network3/3
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Elite institution pipeline (2/2)Frontier geography (1/2)
Concentration intensity3/3
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Dedicated mentor / coach (2/2)
Domain proximity2/2
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Direct domain exposure (1/2)Frontier geography (1/2)Elite institution pipeline (2/2)
Prior reps2/3
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Rare early tools (1/2)Dedicated mentor / coach (2/2)Elite institution pipeline (2/2)
Structural wave / timing2/3
Externalmedium confidence
A structural wave is external to the person, even when their position improved access to it.
Frontier geography (1/2)
Capital safety1/2
Advantage-enabledmedium confidence
One or more documented starting advantages plausibly enabled this lever.
Elite institution pipeline (2/2)
This is a bounded inference from the current annotations—not a claim about private effort, merit, or the percentage of Cornelia Bargmann's outcome attributable to any origin.
Luck is not a leftover score.Structural luck, Encounter luck, Event luck, Outcome variance can change every arrow in the path. This successful-only dataset cannot observe the near-identical paths that did not break through, so luck stays visible and unscored.
Within Researchers / independent engineers, Cornelia Bargmann's starting-advantage total is at the 57th percentile. Separately, their built or converted leverage total is at the 92th percentile. Other T1 profiles average 8.9 / 24 starting advantage and 13.6 / 25 leverage. Similar scores appear in other tiers, so these figures describe positioning—not a cause.
Trajectory
- 1981 · age 20
Graduated from University of Georgia
Completed her BS in biochemistry at the University of Georgia.
- 1987 · age 26
Completed PhD at MIT cloning HER2 oncogene
Earned her PhD in cancer biology at MIT under Robert Weinberg, having cloned the neu/HER2 oncogene, a discovery that led to the development of Herceptin.
- 1991 · age 30
Joined UCSF as assistant professor
After a postdoctoral fellowship with H. Robert Horvitz at MIT studying C. elegans, began her faculty career at UCSF.
- 1998 · age 37
Promoted to full professor at UCSF
Achieved the rank of full professor at UCSF, having established her pioneering work on C. elegans olfaction and neural circuits.
- 2004 · age 43
Joined Rockefeller University
Moved to Rockefeller University as head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behaviour.
- 2012 · age 51
Co-chaired NIH BRAIN Initiative
Appointed co-chair of the advisory committee for the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
- 2016 · age 55
Became Head of Science at Chan Zuckerberg Initiative
Appointed Head of Science at the Chan Zuckerberg Initiative, leading the science strategy of the philanthropic organization.
- 2018 · age 57
Awarded Kavli Prize in Neuroscience
Received the Kavli Prize in Neuroscience for her work on the molecular mechanisms and neural circuits underlying behavior.
Primary leverage engine
Technical depth
Scarce technical / intellectual depth
Secondary engine
Elite academic network
Built/converted leverage
16 / 25
evidence: High
Built or converted leverage
Multiplying capacity documented later in the path. Measures what was present, not whether it was inherited, earned, self-built, external, or mixed.
Started serious reps before 20
0/1
Elite ecosystem network
3/3
Structural wave / timing
2/3
Concentration intensity
3/3
Starting-advantage scores (0–2 each)
Access or conditions documented near the beginning of the path. Zero means "no clear evidence in reviewed sources," not "advantage was absent."
Family financial platform
0/2
Parent / family domain
0/2
Inherited audience / network
0/2
Elite institution pipeline
2/2
Dedicated mentor / coach
2/2
Exceptional peer / cofounder
0/2
Direct domain exposure
1/2
Prodigy / innate ability
0/2
Adversity / constraint catalyst
0/2
Family context
Born in 1961 in Virginia and raised in Athens, Georgia; not much is documented about her family's financial status in reviewed sources.
Parent / family domain
Not documented in reviewed sources.
Archetype & tags
Mentor-acceleratedMIT/Weinberg pipelineHER2 oncogene discoveryWhitehead Institutecancer biology frontier
Evidence summary
Bargmann grew up in Athens, Georgia, and studied biochemistry at the University of Georgia before joining Robert Weinberg's lab at MIT's Whitehead Institute. As a PhD student, she cloned the neu/HER2 oncogene, demonstrating it encoded a receptor tyrosine kinase. This work directly led to the development of Herceptin, a targeted breast cancer therapy. The MIT/Whitehead ecosystem and Weinberg's mentorship were crucial.
advantage confidence: High · source count: 3 · audit: not_independently_audited · status: subagent_researched_beta
Sources
Related — same primary engine